Cellectis S A : Report of the board of directors to the combined shareholders' meeting - June 27, 2023

CELLECTIS


A corporation with a share capital of 2,779,188.40 euros


Headquarters: 8, rue de la Croix Jarry - 75013 Paris


... | June 1, 2023

Related Keywords

Berlin ,Germany ,Paris ,France General ,France ,Switzerland ,Belgium ,United States ,French ,American ,Pierre Bastid ,Laurent Arthaud ,Donald Bergstrom ,Axel Sven Malkomes ,Croix Jarry ,Institut Pasteur ,David Sourdive ,Rainer Boehm ,Jean Pierre Garnier ,Annick Schwebig ,Nextvivo Inc ,Carrier Global Corp ,Humanigen Inc ,Nasdaq ,Tribogenics Inc ,Fusion Pharmaceuticals ,European Investment Bank ,Company Board Of Directors ,Investment Bank ,Calyxt Inc ,Iovance Biotherapeutics Inc ,D Ctv Center New York ,Chartier Consulting ,Harvard Medical School ,Prior To Iovance Biotherapeutics Inc ,Life Sciences ,Commercial Code ,French Monetary ,Financial Code ,French Commercial Code ,French Commerciaal Code ,Nasdaq Rules ,Chief Executive Officer ,Deputy Chief Executive Officer ,Executive Vice ,Berlin Cures ,Omega Therapeutics ,Louis Pasteur De Strasbourg ,Harvard Medical ,General Meeting ,Cellectis Sa Stock Exchange ,News ,Information ,Press Release ,Corporation ,Ith ,Phare ,Capital ,F ,Ue ,Groix ,Larry ,5013 Alcls Fr0010425595 ,